Drug recall D-0184-2023
Product
Vancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vials per carton, Rx only, Distributed by: Hospira, Inc., Lake Forest, IL 60045. NDC Vial 0409-3515-11; NDC Carton 0409-3515-01
Reason for recall
Presence of Particulate Matter: Glass particulate matter detected in injectable.
Lots and codes
Lot: 33045BA, EXP 1SEP2023
Recall details
- Recalling firm
- Pfizer Inc., New York, NY
- Quantity
- 89,700 vials
- Distribution
- USA nationwide and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- December 22, 2022
- Terminated
- August 7, 2024
Related products
- Vancomycin Hydrochloride – drug information
- NDC 0409-4332 Vancomycin Hydrochloride · Vancomycin Hydrochloride 500 mg/1 · Hospira, Inc.
- NDC 0409-6531 Vancomycin Hydrochloride · Vancomycin Hydrochloride 750 mg/1 · Hospira, Inc.
- NDC 0409-3515 Vancomycin Hydrochloride · Vancomycin Hydrochloride 1.5 g/1 · Hospira, Inc.
- NDC 0409-6533 Vancomycin Hydrochloride · Vancomycin Hydrochloride 1 g/1 · Hospira, Inc.